Is urotensin II a new inflammatory marker of inflammatory bowel disease? [0.03%]
尿肽素II是炎症性肠病的新炎症标志物吗？
Marta Vernero
Marta Vernero
Efficacy of intestinal microbiota transplantation in ulcerative colitis: a review of current literature and knowledge [0.03%]
肠微生物移植治疗溃疡性结肠炎的疗效：目前文献和知识回顾
Krista M Newman,Byron P Vaughn
Krista M Newman
Inflammatory bowel disease (IBD) results in chronic inflammation in the intestine and is thought to arise from an abnormal immune response to host commensal bacteria. The current treatment paradigm for IBD is focused on suppression of the i...
Fabrizio M Gili,Stefano Rizza
Fabrizio M Gili
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study [0.03%]
溃疡性结肠炎患者尿紧张素Ⅱ受体的表达：一项初步研究
Antonietta G Gravina,Marcello Dallio,Concetta Tuccillo et al.
Antonietta G Gravina et al.
Background: Urotensin II (U-II) is a vasoactive peptide that interacts with a specific receptor named UTR. Recently, our group has demonstrated increased UTR expression in both human colon adenocarcinoma cell lines and ad...
Blue light emitting diodes cripple Helicobacter pylori by targeting its virulence factors [0.03%]
蓝光发光二极管通过靶向致病因子来抑制幽门螺旋杆菌生长
Homa Darmani,Ehda Am Smadi,Sereen Mb Bataineh
Homa Darmani
Background: The endogenous photosensitizing porphyrins in Helicobacter pylori (H. pylori), make blue light therapy an attractive addition to the armamentarium in the war against this very prevalent and difficult to treat ...
Microbial dysbiosis in inflammatory bowel diseases: results of a metagenomic study in Saudi Arabia [0.03%]
Meta基因组学研究显示：沙特阿拉伯炎症性肠病患者的肠道菌群失调
Ibrahim Masoodi,Ali S Alshanqeeti,Shameem Ahmad et al.
Ibrahim Masoodi et al.
Background: The intestinal microbiota plays an essential role in the pathogenesis of ulcerative colitis (UC)and Crohn disease (CD). Methods: ...
Cancer risk, screening and surveillance in primary sclerosing cholangitis [0.03%]
原发性硬化性胆管炎的癌症风险、筛查和监测措施
David M Chascsa,Keith D Lindor
David M Chascsa
Primary sclerosing cholangitis (PSC) is a rare chronic inflammatory condition mainly of the large bile ducts, affecting predominantly young men, and is associated with the presence of inflammatory bowel disease. There is no known cure for P...
Barbara Imperatrice,Gabriele Giudici,Alfredo Marzano
Barbara Imperatrice
Complete response for 36 months after BRAF and MEK inhibitor therapy for locally advanced gallbladder melanoma [0.03%]
布/MEK抑制剂治疗后局部晚期胆囊黑色素瘤的长期疗效及安全性（随访36个月）
Seifeldin Hakim,Molly Orosey,Ahmed Edhi et al.
Seifeldin Hakim et al.
Gastroenterologist successfully extracting at EGD a blunt, semi-rigid, foreign body tightly impacted at the UES [0.03%]
胃镜下食管上括约肌异物取出术
Mitchell S Cappell,Mihajlo Gjeorgjievski
Mitchell S Cappell